Date/Time: Tuesday, February 22nd 2022 at 3:00 p.m. Eastern
Presenter: Dr. Deborah Gelinas, MD, Executive Director of Neuromuscular Medicine for Argenx.
Webinar presentation of newly FDA Approved VYVGART™ (efgartigimod alfa-fcab) for the treatment of adult patients with gMG who are anti-AChR antibody positive